Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-28

FDA Approved: URSODIOL — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

FDA approved a supplemental application for URSODIOL by Zydus Pharmaceuticals (USA) Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • URSODIOL (ursodiol)

Snippet

SUPPL AP for URSODIOL (URSODIOL)